eyeBrain Medical, Inc.
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses).
The verdict
According to USPTO PatentsView, eyebrain ranks #40,147 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.
- #40,147
- of 49,997 US assignees by volume
- 14th percentile
- by Innovation Score (24.2/100)
- 16.0
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R40147 · US Corporation #40,147 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #40,147/49,997
- PHOTO-FINISH eduPresent
- CPC-NARROW G02C · 5 areas
- INNOV-THIN 24.2/100
- CLAIMS-RICH 16.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: eduPresent LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How eyebrain’s 24.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around eyebrain
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- eyeBrain Medical · this assignee 24
eyeBrain Medical · this assignee
24 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows eyebrain's Innovation Score is 24.2/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for eyebrain?
Each dot is one of eyebrain’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). eyebrain’s own 16.0 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where eyebrain's grants concentrate
eyeBrain Medical, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 66.7% of grants classified under G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses). By volume, eyebrain sits between eLum Technologies, Inc. and iCAD, Inc..
Who files at eyeBrain's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- elum
eLum Technologies, Inc.
6 patents
- equility
eQuility LLC
6 patents
- exithera Pharmace…
eXIthera Pharmaceuticals, Inc.
6 patents
- edupresent
eduPresent LLC
6 patents
- fischer Rohrtechn…
fischer Rohrtechnik GmbH
6 patents
- hubergroup Deutsc…
hubergroup Deutschland GmbH
6 patents
- ibenzer
iBenzer Inc.
6 patents
- icad
iCAD, Inc.
6 patents
- eyebrain Medical ◀
eyeBrain Medical, Inc.
6 patents
What this shows eyeBrain holds 6 patents at rank #44,252, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near eyeBrain
By rank, the assignees closest to #44,252 in granted patent volume.
- eLum Technologies, Inc. #44,248 · 6 patents
- eQuility LLC #44,249 · 6 patents
- eXIthera Pharmaceuticals, Inc. #44,250 · 6 patents
- eduPresent LLC #44,251 · 6 patents
- fischer Rohrtechnik GmbH #44,253 · 6 patents
- hubergroup Deutschland GmbH #44,254 · 6 patents
- iBenzer Inc. #44,255 · 6 patents
- iCAD, Inc. #44,256 · 6 patents
Leaders in G02C (Spectacles)
Other assignees with the most granted patents in eyeBrain's primary technology class.
- Essilor International 397 in class
- Johnson & Johnson Vision Care, Inc. 360 in class
- Snap Inc. 212 in class
- Carl Zeiss Vision International GmbH 149 in class
- Verily Life Sciences LLC 147 in class
- Hoya Lens Thailand Ltd. 114 in class
- Magic Leap, Inc. 109 in class
- Essilor International (Compagnie Generale d'Optique) 109 in class
eyebrain's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 14th percentile higher than 14% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 33.3% |
| 2018 | 2 | 33.3% |
| 2019 | 2 | 33.3% |
Which technologies does eyeBrain Medical, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
eyeBrain Medical, Inc.'s patent record in context - here's where to go next.
- eyeBrain Medical, Inc.'s lead technology class is G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses), 66.7% of its portfolio - see every assignee active in that class. Explore G02C
- Ranked #40,147 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare eyeBrain Medical, Inc. against eLum Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 24.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.